To characterize the contribution of these cells to SARS-CoV-2 pathogenesis, we performed an integrative single cell RNA sequencing (scRNAseq) analysis of CD16+ monocytes obtained from publicly available data of PBMC from healthy people and those with COVID-19. The gene discussed is FCGR3A; the disease is COVID-19.